Oxycodone/naloxone prolonged‐release tablets in patients with moderate‐to‐severe, chronic cancer pain: challenges in the context of hepatic impairment

Le, B.H., Aggarwal, G., Douglas, C. et al. (3 more authors) (2022) Oxycodone/naloxone prolonged‐release tablets in patients with moderate‐to‐severe, chronic cancer pain: challenges in the context of hepatic impairment. Asia-Pacific Journal of Clinical Oncology, 18 (1). pp. 13-18. ISSN 1743-7555

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Le, B.H.
  • Aggarwal, G.
  • Douglas, C.
  • Green, M.
  • Nicoll, A.
  • Ahmedzai, S.
Copyright, Publisher and Additional Information:

© 2021 The Authors. Asia-Pacific Journal of Clinical Oncology published by John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, (http://creativecommons.org/licenses/by-nc-nd/4.0/) which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Keywords: cancer; chronic pain; hepatic impairment; opioid-induced constipation; oxycodone naloxone prolonged release tablet
Dates:
  • Published: February 2022
  • Published (online): 3 March 2021
  • Accepted: 29 December 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 24 Feb 2022 17:09
Last Modified: 24 Feb 2022 17:09
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: 10.1111/ajco.13561
Open Archives Initiative ID (OAI ID):

Export

Statistics